171 related articles for article (PubMed ID: 8626353)
21. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
22. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Keck PE; McElroy SL
J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
[TBL] [Abstract][Full Text] [Related]
23. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
24. Rapid oral loading of extended release divalproex in patients with acute mania.
Miller BP; Perry W; Moutier CY; Robinson SK; Feifel D
Gen Hosp Psychiatry; 2005; 27(3):218-21. PubMed ID: 15882770
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of divalproex versus lithium.
Baker CB; Woods SW; Sernyak MJ
J Clin Psychiatry; 1997 Aug; 58(8):363-4. PubMed ID: 9515977
[No Abstract] [Full Text] [Related]
26. Secondary mania: diagnosis and treatment.
Evans DL; Byerly MJ; Greer RA
J Clin Psychiatry; 1995; 56 Suppl 3():31-7. PubMed ID: 7883741
[TBL] [Abstract][Full Text] [Related]
27. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
28. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
Glazer WM; Ereshefsky L
J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
[TBL] [Abstract][Full Text] [Related]
29. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
30. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
[TBL] [Abstract][Full Text] [Related]
31. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
Bowden CL
J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness and HRQOL outcomes of divalproex sodium (Depakote) in bipolar disorder.
Revicki DA
Expert Rev Pharmacoecon Outcomes Res; 2004 Feb; 4(1):9-14. PubMed ID: 19807331
[TBL] [Abstract][Full Text] [Related]
33. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.
Calabrese JR; Shelton MD; Rapport DJ; Youngstrom EA; Jackson K; Bilali S; Ganocy SJ; Findling RL
Am J Psychiatry; 2005 Nov; 162(11):2152-61. PubMed ID: 16263857
[TBL] [Abstract][Full Text] [Related]
34. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
35. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
Bowden CL; Collins MA; McElroy SL; Calabrese JR; Swann AC; Weisler RH; Wozniak PJ
Neuropsychopharmacology; 2005 Oct; 30(10):1932-9. PubMed ID: 15956987
[TBL] [Abstract][Full Text] [Related]
36. Effects of divalproex versus lithium on length of hospital stay among patients with bipolar disorder.
Dalkilic A; Diaz E; Baker CB; Pearsall HR; Woods SW
Psychiatr Serv; 2000 Sep; 51(9):1184-6. PubMed ID: 10970927
[TBL] [Abstract][Full Text] [Related]
37. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
[TBL] [Abstract][Full Text] [Related]
38. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
Roick C; Ahrens B; Becker T
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.
Bowden CL; Brugger AM; Swann AC; Calabrese JR; Janicak PG; Petty F; Dilsaver SC; Davis JM; Rush AJ; Small JG
JAMA; 1994 Mar 23-30; 271(12):918-24. PubMed ID: 8120960
[TBL] [Abstract][Full Text] [Related]
40. Valproate oral loading in the treatment of acute mania.
Keck PE; McElroy SL; Tugrul KC; Bennett JA
J Clin Psychiatry; 1993 Aug; 54(8):305-8. PubMed ID: 8253698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
